The Invisible Divide in Diabetes Care: Why Type 2 Patients Are Still Paying to Bleed
The future standard should be simple: If a patient requires intensive insulin management, that patient deserves access to modern glucose monitoring technology, regardless of whether the diagnosis says Type 1 or Type 2.
That is not radical. That is modern medicine catching up with reality. “Update: After consistently following my treatment plan and multiple discussions with my endocrinologist, I have been approved for a continuous glucose sensor as a person with type 2 diabetes. This remains an exception rather than standard practice.”